[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019 Gouty Arthritis (Gout) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 177 pages | ID: 2A2DE666E99EN
VPAResearch

US$ 1,799.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global clinical trial report- “2019 Gouty Arthritis (Gout) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Gouty Arthritis (Gout). It presents in-depth analysis of Gouty Arthritis (Gout) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Gouty Arthritis (Gout).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Gouty Arthritis (Gout) clinical trials by-
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Gouty Arthritis (Gout)

The research work is prepared through extensive and continuous research on Gouty Arthritis (Gout) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Gouty Arthritis (Gout) patients are identified
  • The report includes panorama of Gouty Arthritis (Gout) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Gouty Arthritis (Gout) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Gouty Arthritis (Gout) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Gouty Arthritis (Gout) Clinical Trials by Region
  2.2.2 Average Enrollment of Gouty Arthritis (Gout) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Gouty Arthritis (Gout) Treatment, 2019

3. REGION WISE GOUTY ARTHRITIS (GOUT) CLINICAL TRIALS

3.1 Asia Pacific Gouty Arthritis (Gout) Clinical Trials by Country
3.2 Europe Gouty Arthritis (Gout) Clinical Trials by Country
3.3 North America Gouty Arthritis (Gout) Clinical Trials by Country
3.4 Middle East and Africa Gouty Arthritis (Gout) Clinical Trials by Country
3.5 South and Central America Gouty Arthritis (Gout) Clinical Trials by Country

4. GOUTY ARTHRITIS (GOUT) CLINICAL TRIAL TRENDS

4.1 Start Year wise Gouty Arthritis (Gout) Clinical Trials
4.2 Phase wise Gouty Arthritis (Gout) Clinical Trials
4.3 Trial Status wise Gouty Arthritis (Gout) Clinical Trials
4.4 Trial Type wise Gouty Arthritis (Gout) Clinical Trials

5. GOUTY ARTHRITIS (GOUT) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Gouty Arthritis (Gout) Trials by Year
5.2 Average Enrollment in Gouty Arthritis (Gout) Trials by Phase
5.3 Average Enrollment in Gouty Arthritis (Gout) Trials by Status
5.4 Average Enrollment in Gouty Arthritis (Gout) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN GOUTY ARTHRITIS (GOUT) CLINICAL TRIALS

6.1 Gouty Arthritis (Gout) Trials by Sponsor Type
6.2 Gouty Arthritis (Gout) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Gouty Arthritis (Gout) Trials- Phase
7.2 Gouty Arthritis (Gout) Trials- Phase
7.3 Gouty Arthritis (Gout) Trials- Phase
7.4 Gouty Arthritis (Gout) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

LIST OF FIGURES

Figure 1: Gouty Arthritis (Gout) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Figure 7: North America – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Figure 9: Gouty Arthritis (Gout) Clinical Trials by Phase
Figure 10: Gouty Arthritis (Gout) Clinical Trials by Trial Status
Figure 11: Gouty Arthritis (Gout) Clinical Trials by Type
Figure 12: Gouty Arthritis (Gout) Clinical Trials by Sponsor Type
Figure 13: Gouty Arthritis (Gout) Clinical Trials by Leading Sponsors
Figure 14: Gouty Arthritis (Gout) Average Enrollment by Phase
Figure 15: Gouty Arthritis (Gout) Average Enrollment by Trial Status
Figure 16: Gouty Arthritis (Gout) Average Enrollment by Type
Figure 17: Gouty Arthritis (Gout)- Average Enrolment by Type of Sponsors
Figure 18: Gouty Arthritis (Gout)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

LIST OF TABLES

Table 1: Gouty Arthritis (Gout) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Table 5: Europe – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Table 7: North America – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Gouty Arthritis (Gout) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Gouty Arthritis (Gout) Average Enrollment by Phase
Table 15: Gouty Arthritis (Gout) Average Enrollment by Trial Status
Table 16: Gouty Arthritis (Gout) Average Enrollment by Type
Table 17: Gouty Arthritis (Gout)- Average Enrolment by Type of Sponsors
Table 18: Gouty Arthritis (Gout)- Enrolment by Leading Sponsors


More Publications